JM

John MacLean

Merck: 8 patents #20 of 1,208Top 2%
LY Lycera: 3 patents #6 of 26Top 25%
Overall (2017): #11,580 of 506,227Top 3%
8
Patents 2017

Issued Patents 2017

Patent #TitleCo-InventorsDate
9844553 Pyrazolopyridyl compounds as aldosterone synthase inhibitors D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke, Scott B. Hoyt +6 more 2017-12-19
9809561 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, Brian M. Andresen, Kenneth J. Barr +9 more 2017-11-07
9783511 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +6 more 2017-10-10
9745265 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Corey E. Bienstock, Hongjun Zhang, Richard Thomas Beresis, Dongshan Zhang +3 more 2017-08-29
9663522 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony, Matthew H. Daniels +2 more 2017-05-30
9663502 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +9 more 2017-05-30
9567333 Triazolopyridyl compounds as aldosterone synthase inhibitors D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Andrew Cooke, Scott B. Hoyt +6 more 2017-02-14
9556168 N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Corey E. Bienstock, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony +2 more 2017-01-31